ArcticZymes Technologies ASA (OSE: "AZT") is pleased to invite investors, analysts, media and other stakeholders to its upcoming Capital Markets Day. The objective of the day is to provide clearer insight into ArcticZymes' position, ambitions, strategic direction and long-term value creation framework.
Date: 6 March 2026
Venue: Smålandsgatan 17, Stockholm (Sweden) / virtually (details below)
Time: Doors open at 08:30
Preliminary agenda:
· 0830-0900: Registration and coffee
· 0900-0915: Introduction
· 0915-1200: Capital Markets Day & Q&A
· 1200-1230: Lunch and investor meetings
At the Capital Markets Day, management will present ArcticZymes' value proposition, key market opportunities and strategic priorities going forward. The presentation will also highlight the company's commercial strength and illustrate how ArcticZymes is scaling its enzyme platform across high-growth markets.
Following the CMD, participants are invited to stay for an informal lunch and engage in short meetings with management.
Key speakers and high-level topics:
· Michael Akoh (CEO): Company introduction, strategic direction, summary & outlook
· Steve Dey (Director of Product Management & Marketing): Market opportunity and growth strategy
· Paul Blackburn (CCO): Commercial strength
· Børge Sørvoll (CFO): Financial profile
· Customer representative: Lee Davies (Senior Director Process Research & Dev - OXB)
· Customer representative: Rafi Ahmad (Professor University of Inland & UiT, Norway)
Participation:
You can attend the event in person or participate via a live webcast. Please register for the in-person event by emailing ir@arcticzymes.com.
We look forward to welcoming you and hope to see you in Stockholm.
The webcast will be accessible through the following link: https://www.finwire.tv/webcast/arcticzymes-technologies/cmd/
For further information, please contact:
Børge Sørvoll
CFO
ir@arcticzymes.com
+47 952 90 187